Drugs in the Pipeline for HBV
Under a Creative Commons license
open access
Keywords
HBV cure
cccDNA
Core protein inhibitor
siRNA
Entry inhibitor
TLR agonist
Immunotherapy
Cited by (0)
Disclosure Statement: U. Lopatin is an employee of Assembly Biosciences.
© 2019 The Author. Published by Elsevier Inc.